Table I.

Unadjusted and adjusted^∗ relative risks (95% CI) for outcome achievement at 12 months following biologic initiation for plaque psoriasis patients with vs without history of diabetes

Outcome	No. of achieved outcomes at 12-mo		Unadjusted RR (95% CI)	Adjusted RR (95% CI)
	Diabetes	No diabetes
	(N = 789)	(N = 4,083)
PASI90, n (%)	303 (38.4%)	1,970 (48.3%)	0.80 (0.71-0.89)	0.83 (0.72-0.95)
PASI75, n (%)	418 (53.0%)	2,542 (62.3%)	0.85 (0.78-0.93)	0.89 (0.80-0.98)

^∗Adjusted models included the following: Age, sex, race, ethnicity, insurance (this was a variable created so that the levels were mutually exclusive, and they included Private only, Medicare only, Medicaid only, none, and 2 or more insurances), education, work status, geographic region, smoking status, drinking habits, obesity, psoriasis duration, comorbid psoriatic arthritis, biologic experience, and drug class.